Article
Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizers.
Journal of clinical psychopharmacology - 1 Jun 2000
DeVane C L, Markowitz J S, Carson S W, Boulton D W, Gill H S, Nahas Z, Risch S C
Abstract excerpt
Six adults phenotyped as either extensive (N = 4) or poor (N = 2) metabolizers for cytochrome P450 (CYP) 2D6 were given a 10-mg oral dose of methylphenidate (MPH) on two separate occasions with and without quinidine, a potent CYP2D6 inhibitor. Quinidine had no significant effect on the pharmacokinetics of either MPH or ritalinic acid, its major metabolite, in either group of CYP2D6 metabolizers. These data...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
